[Disclosure] Alteogen(196170) Issued Preliminary ‘Investment Warning’ Notice and Designated as ‘Investment Caution’ Stock on February 27

Source Fact: Financial Supervisory Service DART / 2024-02-26

Disclosure Type: Designation of Investment Caution Stock (Preliminary Warning for Investment Warning Stock)

💡 3-Second Summary

Due to an intense price acceleration where its stock price shot up over 60% in 5 days and 100% in 15 days, biotech firm Alteogen has received a preliminary warning for an ‘Investment Warning Stock’ designation and will be classified as an ‘Investment Caution Stock’ for one day on February 27.

📊 1. [Summary of Core Disclosure Content and Major Figures]

• Target Stock: Alteogen Co., Ltd. Common Stock (Ticker: 196170)
• Effective Date of Caution Designation: February 27, 2024 (Designated as an Investment Caution Stock for 1 trading day)
• Reason for Preliminary Warning: The closing price on February 26, 2024, moved up by 60% or more compared to the closing price 5 trading days prior, and by 100% or more compared to the closing price 15 trading days prior, fulfilling the structural parameters for sharp short-term and mid-term price appreciation.
• Conditions for Final ‘Investment Warning Stock’ Designation: Within 10 trading days starting from the preliminary notice date (with the review window extending from the initial date of February 27 to March 12, 2024), the stock will be upgraded to an Investment Warning Stock on the following day if all criteria under either [1] Short-term Surge or [2] Mid-to-Long-term Surge are simultaneously satisfied on any specific evaluation day (T):
  • [1] Short-term Surge Parameters (All 3 items must be met):
    1. The closing price on day T is 60% or higher than the closing price 5 trading days prior (T-5).
    2. The closing price on day T is the highest closing price over the past 15 consecutive trading days (including day T).
    3. The 5-day rate of appreciation relative to day T-5 is at least 5 times that of the composite stock price index over the same period.
  • [2] Mid-to-Long-term Surge Parameters (All 3 items must be met):
    1. The closing price on day T is 100% or higher than the closing price 15 trading days prior (T-15).
    2. The closing price on day T is the highest closing price over the past 15 consecutive trading days (including day T).
    3. The 15-day rate of appreciation relative to day T-15 is at least 3 times that of the composite stock price index over the same period.
• Review Schedule Note: The review process begins on February 27, 2024. If the conditions are not satisfied, the evaluation slides forward daily until March 12, 2024. The schedule remains subject to change based on potential trading suspensions.
• Governing Regulation: Article 5-3 of the Market Surveillance Regulation and Article 3-3 of the Enforcement Rules of the same regulation.

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing indicates a regulatory market intervention mechanism enforced by the Korea Exchange (KRX) to manage heightened price vectors and ensure investor caution against short-term market overheating. It represents a systematic trading restriction triggered by mathematical price parameters rather than a development identifying an update in Alteogen’s underlying operational fundamental, active clinical trials, or fiscal earnings performance.

The preliminary warning may generate a near-term psychological cooling effect on market participants during the caution designation window on February 27. If buying volume persists throughout the evaluation window (February 27 to March 12), forcing the stock to hit new 15-day highs while heavily outperforming the benchmark index, a formal upgrade to an ‘Investment Warning Stock’ could occur. Since progressing to the Investment Warning tier completely restricts credit leverage and implements a mandatory 100% upfront cash deposit rule, investors are advised to monitor the daily closing price metrics relative to index trends carefully rather than trading purely on momentum vectors.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen’s powerful market rally has officially caught the attention of regulatory watchdogs, resulting in a preliminary ‘Investment Warning Stock’ alert. A vertical expansion over the past few weeks—surging 60% in 5 sessions and 100% in 15 sessions—has pushed the stock into the ‘Investment Caution’ bracket for February 27. While this temporary designation lasts for just one session, intraday volatility may spike. Given that the window for a potential upgrade to an Investment Warning status stays wide open until March 12, stepping back from emotional FOMO and objectively checking the regulatory resistance boundaries would be a safer route for portfolio protection.

📢 Disclaimer and Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.